MarketCap
Facebook
X
TelegramAnnual report 2024
added 12-13-2025
Check-Cap Ltd. Total Current Liabilities 2011-2025 | CHEK
Annual Total Current Liabilities Check-Cap Ltd.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.81 M | 1.33 M | 3.41 M | 4.04 M | 2.98 M | 2.8 M | 2.22 M | 1.56 M | 1.37 M | 2.07 M | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 4.04 M | 1.33 M | 2.36 M |
Total Current Liabilities of other stocks in the Diagnostics research industry
| Issuer | Total Current Liabilities | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Akumin
AKU
|
169 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Burning Rock Biotech Limited
BNR
|
372 M | $ 16.9 | 7.3 % | $ 183 M |  China |
 |
Accelerate Diagnostics
AXDX
|
66.6 M | - | -61.36 % | $ 2.46 M |  USA |
 |
Biocept
BIOC
|
5.51 M | - | -13.05 % | $ 7.29 M | USA |
 |
BioNano Genomics
BNGO
|
37.3 M | $ 1.57 | -3.08 % | $ 2 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
13.8 M | - | - | $ 562 M |  Britain |
 |
Castle Biosciences
CSTL
|
49.4 M | $ 38.44 | -0.5 % | $ 1.07 B | USA |
 |
DarioHealth Corp.
DRIO
|
12.5 M | $ 12.0 | 0.93 % | $ 340 M |  Israel |
 |
Chembio Diagnostics
CEMI
|
39.3 M | - | 0.22 % | $ 16.8 M | USA |
 |
DexCom
DXCM
|
1.56 B | $ 66.39 | -0.85 % | $ 25.6 B | USA |
 |
Danaher Corporation
DHR
|
6.8 B | $ 226.5 | - | $ 166 B | USA |
 |
Exact Sciences Corporation
EXAS
|
732 M | $ 101.57 | 0.07 % | $ 18.8 B | USA |
 |
Fulgent Genetics
FLGT
|
72.9 M | $ 26.81 | -1.22 % | $ 811 M | USA |
 |
Global Cord Blood Corporation
CO
|
647 M | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
54.2 M | - | 1.08 % | $ 308 M | USA |
 |
DermTech
DMTK
|
13.4 M | - | -11.32 % | $ 2.94 M | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
1.27 B | - | - | $ 10.7 B | USA |
 |
CareDx, Inc
CDNA
|
78.1 M | $ 19.74 | -3.99 % | $ 1.06 B | USA |
 |
Celcuity
CELC
|
31.7 M | $ 102.0 | -3.09 % | $ 4.02 B | USA |
 |
Enzo Biochem
ENZ
|
24.8 M | - | -8.98 % | $ 14.8 K | USA |
 |
Anixa Biosciences
ANIX
|
2.5 M | $ 3.53 | -1.4 % | $ 113 K | USA |
 |
Co-Diagnostics
CODX
|
5.75 M | $ 0.31 | -9.4 % | $ 9.1 M | USA |
 |
Quidel Corporation
QDEL
|
337 M | $ 28.81 | 0.03 % | $ 1.21 B | USA |
 |
IQVIA Holdings
IQV
|
6.96 B | $ 222.3 | 0.04 % | $ 40.3 B | USA |
 |
Guardant Health
GH
|
226 M | $ 103.47 | 1.37 % | $ 12.7 B | USA |
 |
Aspira Women's Health
AWH
|
5.78 M | - | -6.19 % | $ 10.5 M | USA |
 |
Heska Corporation
HSKA
|
39.6 M | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
8.27 M | - | -20.0 % | $ 1.06 M | USA |
 |
Illumina
ILMN
|
1.55 B | $ 133.88 | -0.73 % | $ 21.3 B | USA |
 |
Charles River Laboratories International
CRL
|
994 M | $ 196.14 | 1.64 % | $ 10.1 B | USA |
 |
Quotient Limited
QTNT
|
59.5 M | - | -11.32 % | $ 1.1 M |  Schweiz |
 |
Quest Diagnostics Incorporated
DGX
|
2.17 B | $ 183.36 | 0.47 % | $ 20.4 B | USA |
|
Biodesix
BDSX
|
14.3 M | $ 7.56 | -3.63 % | $ 980 M | USA |
 |
Mettler-Toledo International
MTD
|
1.17 B | $ 1 410.24 | 1.17 % | $ 29.9 B | Schweiz |
 |
Laboratory Corporation of America Holdings
LH
|
3.33 B | $ 262.29 | -0.71 % | $ 22 B | USA |
 |
Myriad Genetics
MYGN
|
164 M | $ 7.01 | -2.84 % | $ 635 M | USA |
 |
ICON Public Limited Company
ICLR
|
2.8 B | $ 183.39 | -1.71 % | $ 15.1 B |  Irlanda |
 |
IDEXX Laboratories
IDXX
|
1.07 B | $ 701.16 | -0.43 % | $ 57.8 B | USA |
 |
Lantheus Holdings
LNTH
|
241 M | $ 67.34 | 1.08 % | $ 4.66 B | USA |
 |
NeoGenomics
NEO
|
301 M | $ 12.07 | 1.81 % | $ 1.53 B | USA |
 |
Neogen Corporation
NEOG
|
174 M | $ 6.8 | -0.95 % | $ 1.47 B | USA |
 |
Agilent Technologies
A
|
1.71 B | $ 140.63 | 0.69 % | $ 42.8 B | USA |
 |
Biomerica
BMRA
|
1.74 M | $ 2.56 | 0.29 % | $ 5.88 M | USA |
 |
Bioventus
BVS
|
175 M | $ 7.59 | 0.53 % | $ 475 M | USA |
 |
Motus GI Holdings
MOTS
|
3.27 M | - | -34.28 % | $ 263 K | Israel |